First Interstate Bank’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,845
Closed -$194K 582
2019
Q3
$194K Hold
17,845
0.04% 181
2019
Q2
$167K Hold
17,845
0.04% 197
2019
Q1
$219K Hold
17,845
0.05% 173
2018
Q4
$211K Buy
17,845
+1,750
+11% +$24K 0.05% 164
2018
Q3
$232K Buy
16,095
+700
+5% +$9.68K 0.05% 168
2018
Q2
$229K Sell
15,395
-920
-6% -$12.8K 0.05% 173
2018
Q1
$213K Sell
16,315
-550
-3% -$7.23K 0.05% 177
2017
Q4
$212K Hold
16,865
0.05% 173
2017
Q3
$218K Hold
16,865
0.05% 174
2017
Q2
$250K Buy
16,865
+1,405
+9% +$19.6K 0.05% 156
2017
Q1
$186K Buy
15,460
+2,435
+19% +$30.8K 0.04% 185
2016
Q4
$180K Hold
13,025
0.04% 186
2016
Q3
$175K Buy
13,025
+435
+3% +$5.27K 0.04% 203
2016
Q2
$135K Buy
12,590
+2,210
+21% +$24.4K 0.03% 223
2016
Q1
$109K Hold
10,380
0.02% 250
2015
Q4
$123K Buy
10,380
+6,315
+155% +$77.6K 0.03% 250
2015
Q3
$47K Buy
+4,065
New +$53.9K 0.01% 376

Other funds holding LFCR

First Interstate Bank's LFCR Position: Q4 2019 in Review

First Interstate Bank sold out of Lifecore Biomedical (LFCR) in Q4 2019, closing a stake of 17,845 shares — an estimated $194K sold.

First Interstate Bank first reported a position in LFCR in Q3 2015 and held it in 17 quarters. The position peaked at $250K in Q2 2017. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2019.

  • First Interstate Bank reported no remaining Lifecore Biomedical position as of Q4 2019 after selling out during the quarter.
  • First Interstate Bank sold 17,845 Lifecore Biomedical shares in Q4 2019, an estimated $194K.
  • First Interstate Bank first reported a position in Lifecore Biomedical in Q3 2015 and held it in 17 quarters.
  • First Interstate Bank's Lifecore Biomedical position peaked at $250K in Q2 2017.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2019.

Based on First Interstate Bank's 13F filing for Q4 2019, filed 6 Feb 2020.